Engineered human IgG antibodies with longer serum half-lives in primates

被引:216
作者
Hinton, PR [1 ]
Johlfs, MG [1 ]
Xiong, JM [1 ]
Hanestad, K [1 ]
Ong, KC [1 ]
Bullock, C [1 ]
Keller, S [1 ]
Tang, MT [1 ]
Tso, JY [1 ]
V squez, M [1 ]
Tsurushita, N [1 ]
机构
[1] Prot Design Labs Inc, Fremont, CA 94555 USA
关键词
D O I
10.1074/jbc.C300470200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The neonatal Fe receptor (FcRn) plays an important role in regulating the serum half-lives of IgG antibodies. A correlation has been established between the pH-dependent binding affinity of IgG antibodies to FcRn and their serum half-lives in mice. In this study, molecular modeling was used to identify Fe positions near the FcRn binding site in a human IgG antibody that, when mutated, might alter the binding affinity of IgG to FcRn. Following mutagenesis, several IgG, mutants with increased binding affinity to human FcRn at pH 6.0 were identified at Fc positions 250 and 428. These mutants do not bind to human FcRn at pH 7.5. A pharmacokinetics study of two mutant IgG(2) antibodies with increased FcRn binding affinity indicated that they had serum half-lives in rhesus monkeys similar to2-fold longer than the wild-type antibody.
引用
收藏
页码:6213 / 6216
页数:4
相关论文
共 34 条
[1]  
[Anonymous], [No title captured]
[2]   CRYSTAL-STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR WITH FC [J].
BURMEISTER, WP ;
HUBER, AH ;
BJORKMAN, PJ .
NATURE, 1994, 372 (6504) :379-383
[3]   CLONING OF DECAY-ACCELERATING FACTOR SUGGESTS NOVEL USE OF SPLICING TO GENERATE 2 PROTEINS [J].
CARAS, IW ;
DAVITZ, MA ;
RHEE, L ;
WEDDELL, G ;
MARTIN, DW ;
NUSSENZWEIG, V .
NATURE, 1987, 325 (6104) :545-549
[4]  
CO MS, 1992, J IMMUNOL, V148, P1149
[5]  
Cole MS, 1997, J IMMUNOL, V159, P3613
[6]   Increasing the affinity of a human IgG1, for the neonatal Fc receptor: Biological consequences [J].
Dall'Acqua, WF ;
Woods, RM ;
Ward, ES ;
Palaszynski, SR ;
Patel, NK ;
Brewah, YA ;
Wu, H ;
Kiener, PA ;
Langermann, S .
JOURNAL OF IMMUNOLOGY, 2002, 169 (09) :5171-5180
[7]  
EHRLICH P H, 1992, Human Antibodies and Hybridomas, V3, P2
[8]   Increasing the serum persistence of an IgG fragment by random mutagenesis [J].
Ghetie, V ;
Popov, S ;
Borvak, J ;
Radu, C ;
Matesoi, D ;
Medesan, C ;
Ober, RJ ;
Ward, ES .
NATURE BIOTECHNOLOGY, 1997, 15 (07) :637-640
[9]   Multiple roles for the major histocompatibility complex class I-related receptor FcRn [J].
Ghetie, V ;
Ward, ES .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :739-766
[10]   Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice [J].
Ghetie, V ;
Hubbard, JG ;
Kim, JK ;
Tsen, MF ;
Lee, YF ;
Ward, ES .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (03) :690-696